St. Jude Medical (STJ) Reports In-Line Q2 EPS

St. Jude Medical (NYSE: STJ) reported Q2 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.55 billion.

Third Quarter and Full-Year 2016 Sales and Earnings Guidance

Due to the planned merger with Abbott, St. Jude Medical is withdrawing financial guidance for the fiscal year 2016.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• TD Cowen cuts Flowserve to Hold, flags guidance reset risk amid Mideast woes
• KB Home (KBH) PT Raised to $56 at Truist Securities